Methods for improving bioavailability of a renin inhibitor

Details for Australian Patent Application No. 2007324432 (hide)

Owner Novartis AG

Inventors Faller, Thomas; Ottinger, Isabel; Gross, Gerhard; Camenisch, Gian P.

Agent Davies Collison Cave

Pub. Number AU-B-2007324432

PCT Pub. Number WO2008/062066

Priority 06124774.8 24.11.06 EP

Filing date 23 November 2007

Wipo publication date 29 May 2008

Acceptance publication date 14 October 2010

International Classifications

A61K 31/165 (2006.01) - having aromatic rings, e.g. colchicine, atenolol, progabide

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

A61P 9/12 (2006.01) Drugs for disorders of the cardiovascular system

Event Publications

28 May 2009 PCT application entered the National Phase

  PCT publication WO2008/062066 Priority application(s): WO2008/062066

14 October 2010 Application Accepted

  Published as AU-B-2007324432

10 February 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007324435-Rotational atherectomy device with fluid inflatable support elements and distal protection capability

2007324398-Carbonated complex oxides and method for making the same